Biotech · Private company

Travera Inc

Track this companyFree. Adds Travera Inc to your Dealase workspace and tells you when its record changes.

Clinical trials31 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Clinical trials3

A Feasibility Study of Mass-Based Response Drug Screening to Guide Personalized Hyperthermic Intraperitoneal Chemotherapy for High-Grade Appendiceal and Colorectal Adenocarcinoma With Peritoneal MetastasisNA · RECRUITING · started Feb 17, 2026ClinicalTrials.gov NCT07291180 · fetched Nov 12, 2026
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)COMPLETED · started Jul 15, 2022ClinicalTrials.gov NCT05461430 · fetched Nov 12, 2026
Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple MyelomaTERMINATED · started Feb 11, 2019ClinicalTrials.gov NCT03777410 · fetched Nov 12, 2026